EP0173356B1
(en)
*
|
1980-02-29 |
1990-09-19 |
University Patents, Inc. |
Process for preparing modified inorganic polymers
|
US6692941B1
(en)
*
|
1980-08-26 |
2004-02-17 |
The Regents Of The University Of California |
Bovine growth hormone
|
US7101981B1
(en)
|
1980-08-26 |
2006-09-05 |
Regents Of The University Of California |
Bovine growth hormone recombinantly produced in E. coli
|
US4973679A
(en)
*
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
JPS58109498A
(ja)
*
|
1981-08-24 |
1983-06-29 |
Agency Of Ind Science & Technol |
オリゴリボヌクレオチド
|
EP0090789A1
(en)
*
|
1982-03-26 |
1983-10-05 |
Monsanto Company |
Chemical DNA synthesis
|
CA1223831A
(en)
|
1982-06-23 |
1987-07-07 |
Dean Engelhardt |
Modified nucleotides, methods of preparing and utilizing and compositions containing the same
|
DE3382053D1
(de)
*
|
1982-09-30 |
1991-01-17 |
Iro Ab |
Garnspeicher- und zufuehrvorrichtung.
|
US5198540A
(en)
*
|
1982-10-28 |
1993-03-30 |
Hubert Koster |
Process for the preparation of oligonucleotides in solution
|
DE3239887A1
(de)
*
|
1982-10-28 |
1984-05-03 |
Hubert Prof. Dr. 2000 Hamburg Köster |
Verfahren zur herstellung von oligonucleotiden
|
FR2544720B1
(fr)
*
|
1983-04-19 |
1987-11-27 |
California Inst Of Techn |
Installation perfectionnee et procede pour la synthese de composes chimiques, en particulier d'oligonucleotides
|
EP0144386B1
(en)
*
|
1983-06-01 |
1989-09-06 |
Beckman Instruments, Inc. |
Novel preparation of nucleoside phosphoramidite intermediates
|
USRE34069E
(en)
*
|
1983-08-18 |
1992-09-15 |
Biosyntech Gmbh |
Process for the preparation of oligonucleotides
|
DE3329892A1
(de)
|
1983-08-18 |
1985-03-07 |
Köster, Hubert, Prof. Dr., 2000 Hamburg |
Verfahren zur herstellung von oligonucleotiden
|
DE3332068A1
(de)
*
|
1983-09-06 |
1985-03-21 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
|
US5166330A
(en)
*
|
1983-09-06 |
1992-11-24 |
Hoechst Aktiengesellschaft |
Process for the preparation of nucleoside alkyl-aralkyl- and aryl-phosphonites and -phosphonates
|
US5118800A
(en)
*
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
US5015733A
(en)
*
|
1983-12-20 |
1991-05-14 |
California Institute Of Technology |
Nucleosides possessing blocked aliphatic amino groups
|
JPS60197698A
(ja)
*
|
1983-12-20 |
1985-10-07 |
カリフオルニア・インステイテユ−ト・オブ・テクノロジ− |
アミノ誘導化されたオリゴヌクレオチドの合成
|
US5118802A
(en)
*
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
US5821058A
(en)
*
|
1984-01-16 |
1998-10-13 |
California Institute Of Technology |
Automated DNA sequencing technique
|
USRE43096E1
(en)
|
1984-01-16 |
2012-01-10 |
California Institute Of Technology |
Tagged extendable primers and extension products
|
US5367066A
(en)
*
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
JPS61112093A
(ja)
*
|
1984-11-05 |
1986-05-30 |
Wakunaga Seiyaku Kk |
ヌクレオチド誘導体
|
FR2575751B1
(fr)
*
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
DE3507881A1
(de)
*
|
1985-03-06 |
1986-09-11 |
Hoechst Ag, 6230 Frankfurt |
Verfahren und mittel zur phosphorylierung
|
US5252760A
(en)
*
|
1985-03-28 |
1993-10-12 |
Chiron Corporation |
Method of using colored phosphorylating reagents
|
US5332845A
(en)
*
|
1985-03-28 |
1994-07-26 |
Chiron Corporation |
Phosphorylating reagents
|
WO1986006726A1
(en)
*
|
1985-05-15 |
1986-11-20 |
Integrated Genetics, Inc. |
Cytidine analogs
|
US4751177A
(en)
*
|
1985-06-13 |
1988-06-14 |
Amgen |
Methods and kits for performing nucleic acid hybridization assays
|
US4797355A
(en)
*
|
1985-06-13 |
1989-01-10 |
Amgen Inc. |
Methods for attaching polynucleotides to supports
|
US4739044A
(en)
*
|
1985-06-13 |
1988-04-19 |
Amgen |
Method for derivitization of polynucleotides
|
EP0229053A1
(en)
*
|
1985-06-14 |
1987-07-22 |
University Patents, Inc. |
Method for synthesizing deoxyoligonucleotides
|
US4757141A
(en)
*
|
1985-08-26 |
1988-07-12 |
Applied Biosystems, Incorporated |
Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
|
EP0216357A3
(en)
*
|
1985-09-25 |
1988-08-31 |
Nippon Zeon Co., Ltd. |
Phosphoramidite compounds and process for production thereof
|
US4808708A
(en)
*
|
1985-11-02 |
1989-02-28 |
Toagosei Chemical Industry Co., Ltd. |
Phosphorsulfide derivatives of deoxynucleosides or deoxynucleotides and their uses
|
US4855225A
(en)
*
|
1986-02-07 |
1989-08-08 |
Applied Biosystems, Inc. |
Method of detecting electrophoretically separated oligonucleotides
|
US5242823A
(en)
*
|
1986-03-07 |
1993-09-07 |
International Genetic Engineering, Inc. |
Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
|
DE3788914T2
(de)
*
|
1986-09-08 |
1994-08-25 |
Ajinomoto Kk |
Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
|
DE3751468T2
(de)
*
|
1986-10-30 |
1996-02-29 |
Daicel Chem |
Verfahren zur herstellung von oligonukleotiden und verbindungen zur bildung hochmolekularer schutzgruppen.
|
US5071974A
(en)
*
|
1986-10-31 |
1991-12-10 |
Amoco Corporation |
Compositions and methods for the synthesis of oligonucleotides having 5'-phosphorylated termini
|
US4923901A
(en)
*
|
1987-09-04 |
1990-05-08 |
Millipore Corporation |
Membranes with bound oligonucleotides and peptides
|
US5585481A
(en)
*
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
US6031091A
(en)
*
|
1987-09-21 |
2000-02-29 |
Gen-Probe Incorporated |
Non-nucleotide linking reagents for nucleotide probes
|
US4965349A
(en)
*
|
1987-12-24 |
1990-10-23 |
Applied Biosystems, Inc. |
Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
|
WO1989009780A1
(en)
*
|
1988-04-15 |
1989-10-19 |
Chemical Industry Institute Of Toxicology |
Site-specific tritium-labeled oligodeoxynucleotides
|
US5750666A
(en)
*
|
1988-05-26 |
1998-05-12 |
Competitve Technologies, Inc. |
Polynucleotide phosphorodithioate compounds
|
US5278302A
(en)
*
|
1988-05-26 |
1994-01-11 |
University Patents, Inc. |
Polynucleotide phosphorodithioates
|
US5602244A
(en)
*
|
1988-05-26 |
1997-02-11 |
Competitive Technologies, Inc. |
Polynucleotide phosphorodithioate compounds
|
IL90359A0
(en)
*
|
1988-05-26 |
1989-12-15 |
University Patents Inc |
Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and their production
|
US5218103A
(en)
*
|
1988-05-26 |
1993-06-08 |
University Patents, Inc. |
Nucleoside thiophosphoramidites
|
US5216141A
(en)
*
|
1988-06-06 |
1993-06-01 |
Benner Steven A |
Oligonucleotide analogs containing sulfur linkages
|
JPH0291088A
(ja)
*
|
1988-09-29 |
1990-03-30 |
Central Glass Co Ltd |
ホスファイトおよびヌクレオシド‐3’‐ホスファイト誘導体およびこれを用いるオリゴヌクレオチドの合成法
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
EP0428635A4
(en)
*
|
1989-02-24 |
1993-03-10 |
City Of Hope |
Heterologous block oligomers
|
WO1990012022A1
(en)
*
|
1989-03-31 |
1990-10-18 |
University Patents, Inc. |
Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
|
US6254861B1
(en)
|
1989-05-23 |
2001-07-03 |
Chandra Choudhury |
Hematopoietic growth factor derived from T lymphocytes
|
DE3916871A1
(de)
*
|
1989-05-24 |
1990-11-29 |
Boehringer Mannheim Gmbh |
Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
|
GR890100349A
(el)
*
|
1989-05-26 |
1994-03-31 |
University Patents Inc |
Ενώσεις νουκλεοσιδίων & πολυνουκλεοτιδίων, θειοφωσφοραμιδίων & φωσφοροδιθειικών εστέρων & μέθοδοι.
|
US5256775A
(en)
*
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
EP0476071A4
(en)
*
|
1989-06-05 |
1992-11-04 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides and methods for preparing the same
|
US5204455A
(en)
*
|
1989-06-15 |
1993-04-20 |
Froehler Brian C |
Monomethoxytrityl protected oligonucleotides bound to a solid support
|
US6300486B1
(en)
|
1989-06-15 |
2001-10-09 |
Isis Pharmaceuticals, Inc. |
Large scale synthesis of oligonucleotides and their associated analogs
|
US5164491A
(en)
*
|
1989-06-15 |
1992-11-17 |
Gilead Sciences |
Large scale synthesis of oligonucleotides and their associated analogs
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
US7049102B1
(en)
|
1989-09-22 |
2006-05-23 |
Board Of Trustees Of Leland Stanford University |
Multi-gene expression profile
|
US5003097A
(en)
*
|
1989-10-02 |
1991-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for the sulfurization of phosphorous groups in compounds
|
WO1991004983A1
(en)
*
|
1989-10-05 |
1991-04-18 |
University Patents, Inc. |
Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and processes
|
US5914396A
(en)
*
|
1990-01-11 |
1999-06-22 |
Isis Pharmaceuticals, Inc. |
2'-O-modified nucleosides and phosphoramidites
|
EP0463712A3
(en)
|
1990-06-27 |
1992-04-08 |
University Patents, Inc. |
Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
|
US5316908A
(en)
*
|
1990-07-13 |
1994-05-31 |
Life Technologies, Inc. |
Size markers for electrophoretic analysis of DNA
|
WO1992007864A1
(en)
*
|
1990-10-26 |
1992-05-14 |
Genta Incorporated |
Improved process for the synthesis of oligomers
|
US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5594121A
(en)
*
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
US5556961A
(en)
*
|
1991-11-15 |
1996-09-17 |
Foote; Robert S. |
Nucleosides with 5'-O-photolabile protecting groups
|
US8153602B1
(en)
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
US6235887B1
(en)
*
|
1991-11-26 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
|
TW393513B
(en)
*
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
DE69232816T2
(de)
*
|
1991-11-26 |
2003-06-18 |
Isis Pharmaceuticals Inc |
Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen
|
AU3250093A
(en)
|
1991-12-12 |
1993-07-19 |
Gilead Sciences, Inc. |
Nuclease stable and binding competent oligomers and methods for their use
|
US5644048A
(en)
*
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
US5652099A
(en)
*
|
1992-02-12 |
1997-07-29 |
Conrad; Michael J. |
Probes comprising fluorescent nucleosides and uses thereof
|
EP0628051B1
(en)
*
|
1992-02-12 |
2003-07-02 |
Chromagen, Inc. |
Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides
|
US5616700A
(en)
*
|
1992-04-24 |
1997-04-01 |
Beckman Instruments, Inc. |
Processes for synthesizing nucleotides and modified nucleotides using N.sub.
|
US5428148A
(en)
*
|
1992-04-24 |
1995-06-27 |
Beckman Instruments, Inc. |
N4 - acylated cytidinyl compounds useful in oligonucleotide synthesis
|
US5348868A
(en)
*
|
1992-04-24 |
1994-09-20 |
Beckman Instruments, Inc. |
Methods and reagents for cleaving and deprotecting oligonucleotides
|
US5583211A
(en)
*
|
1992-10-29 |
1996-12-10 |
Beckman Instruments, Inc. |
Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
US5428149A
(en)
*
|
1993-06-14 |
1995-06-27 |
Washington State University Research Foundation |
Method for palladium catalyzed carbon-carbon coulping and products
|
JP2798305B2
(ja)
|
1993-06-23 |
1998-09-17 |
ジェネシス ファーマ インコーポレイテッド |
アンチセンスオリゴヌクレオチドおよびヒト免疫不全ウイルス感染におけるその使用
|
US5623068A
(en)
*
|
1994-03-07 |
1997-04-22 |
Beckman Instruments, Inc. |
Synthesis of DNA using substituted phenylacetyl-protected nucleotides
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
US5510476A
(en)
*
|
1994-07-07 |
1996-04-23 |
Isis Pharmaceuticals, Inc. |
Carbocation scavenging during oligonucleotide synthesis
|
US5552471A
(en)
*
|
1994-08-17 |
1996-09-03 |
The Perkin-Elmer Corporation |
Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
|
US5703223A
(en)
*
|
1994-09-02 |
1997-12-30 |
Thomas Jefferson University |
Solid phase synthesis of oligonucleotides with stereospecific substituted phosphonate linkages by pentavalent grignard coupling
|
US6558633B1
(en)
*
|
1994-09-21 |
2003-05-06 |
Isis Pharmaceuticals, Inc. |
Chemical reaction apparatus and methods
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
US5604097A
(en)
|
1994-10-13 |
1997-02-18 |
Spectragen, Inc. |
Methods for sorting polynucleotides using oligonucleotide tags
|
US5717085A
(en)
*
|
1994-11-23 |
1998-02-10 |
Terrapin Technologies, Inc. |
Process for preparing codon amidites
|
US5908926A
(en)
*
|
1995-03-16 |
1999-06-01 |
Duke University |
5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group
|
US5750341A
(en)
|
1995-04-17 |
1998-05-12 |
Lynx Therapeutics, Inc. |
DNA sequencing by parallel oligonucleotide extensions
|
US6531589B1
(en)
*
|
1995-06-01 |
2003-03-11 |
Hybridon, Inc. |
Base protecting groups and synthons for oligonucleotide synthesis
|
US5614622A
(en)
*
|
1995-06-01 |
1997-03-25 |
Hybridon, Inc. |
5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses
|
US6111095A
(en)
*
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
CZ392697A3
(cs)
|
1995-06-07 |
1998-06-17 |
Lynx Therapeutics, Inc. |
Oligonukleotidové značky pro stanovení druhu a identifikaci
|
US5856464A
(en)
*
|
1995-06-07 |
1999-01-05 |
Lajolla Pharmaceutical Company |
Selective capping solution phase oligonucleotide synthesis
|
US5889136A
(en)
*
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
CA2234159A1
(en)
*
|
1995-10-19 |
1997-04-24 |
Alecia Settle |
Method for solution phase synthesis of oligonucleotides
|
US5734041A
(en)
*
|
1995-10-20 |
1998-03-31 |
Mcgill University |
Preparation of chiral phosphorothioate oligomers
|
US6476216B1
(en)
*
|
1995-10-20 |
2002-11-05 |
Mcgill University |
Preparation of phosphorothioate oligomers
|
US6160109A
(en)
*
|
1995-10-20 |
2000-12-12 |
Isis Pharmaceuticals, Inc. |
Preparation of phosphorothioate and boranophosphate oligomers
|
US5705621A
(en)
*
|
1995-11-17 |
1998-01-06 |
Isis Pharmaceuticals, Inc. |
Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same
|
US20030119724A1
(en)
*
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
US5808035A
(en)
*
|
1995-12-08 |
1998-09-15 |
Usher; David A. |
Protected nucleoside and method for its synthesis
|
US5736626A
(en)
|
1996-01-29 |
1998-04-07 |
The Perkin-Elmer Corporation |
Solid support reagents for the direct synthesis of 3'-labeled polynucleotides
|
WO1997036005A1
(en)
*
|
1996-03-26 |
1997-10-02 |
Lynx Therapeutics, Inc. |
Oligonucleotide treatments and compositions for human melanoma
|
US5959100A
(en)
*
|
1996-03-27 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Pyrimidine nucleosides as therapeutic and diagnostic agents
|
US6020481A
(en)
|
1996-04-01 |
2000-02-01 |
The Perkin-Elmer Corporation |
Asymmetric benzoxanthene dyes
|
US5852168A
(en)
*
|
1996-04-30 |
1998-12-22 |
Regents Of The University Of Minesota |
Sulfurization of phosphorus-containing compounds
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US6060240A
(en)
*
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
US6172217B1
(en)
|
1996-12-27 |
2001-01-09 |
Isis Pharmaceuticals Inc. |
Method of synthesizing phosphorothioate oligonucleotides
|
US6103891A
(en)
*
|
1996-12-27 |
2000-08-15 |
Isis Pharmaceuticals, Inc. |
Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
|
US5955600A
(en)
*
|
1996-12-27 |
1999-09-21 |
Isis Pharmaceuticals, Inc. |
Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
|
US5902881A
(en)
|
1997-03-03 |
1999-05-11 |
Isis Pharmaceuticals, Inc. |
Reagent useful for synthesizing sulfurized oligonucleotide analogs
|
US5760209A
(en)
*
|
1997-03-03 |
1998-06-02 |
Isis Pharmaceuticals, Inc. |
Protecting group for synthesizing oligonucleotide analogs
|
EP2208789B1
(en)
*
|
1997-03-12 |
2015-07-22 |
Applied Biosystems, LLC |
DNA polymerases having improved labeled nucleotide incorporation properties
|
WO1998044156A1
(en)
|
1997-03-27 |
1998-10-08 |
Life Technologies, Inc. |
Nucleic acid ladders
|
ATE494371T1
(de)
|
1997-07-15 |
2011-01-15 |
Life Technologies Inc |
Nukleinsäureleitern
|
US6008379A
(en)
|
1997-10-01 |
1999-12-28 |
The Perkin-Elmer Corporation |
Aromatic-substituted xanthene dyes
|
US6583168B1
(en)
|
1997-11-25 |
2003-06-24 |
Applera Corporation |
Sulfonated diarylrhodamine dyes
|
US5936087A
(en)
|
1997-11-25 |
1999-08-10 |
The Perkin-Elmer Corporation |
Dibenzorhodamine dyes
|
US6441150B1
(en)
|
1997-12-16 |
2002-08-27 |
Isis Pharmaceuticals, Inc. |
Compounds for the Synthesis of Nucleotide or oligonucleotide phosphoramidites
|
US7427678B2
(en)
*
|
1998-01-08 |
2008-09-23 |
Sigma-Aldrich Co. |
Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
|
WO1999034920A1
(en)
*
|
1998-01-12 |
1999-07-15 |
Massachusetts Institute Of Technology |
Method and apparatus for performing microassays
|
US6893877B2
(en)
|
1998-01-12 |
2005-05-17 |
Massachusetts Institute Of Technology |
Methods for screening substances in a microwell array
|
US6426185B1
(en)
|
1998-01-16 |
2002-07-30 |
Large Scale Biology Corporation |
Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation
|
US20020164585A1
(en)
*
|
1998-01-16 |
2002-11-07 |
Sean Chapman |
Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
US6303848B1
(en)
|
1998-01-16 |
2001-10-16 |
Large Scale Biology Corporation |
Method for conferring herbicide, pest, or disease resistance in plant hosts
|
US20030027173A1
(en)
*
|
1998-01-16 |
2003-02-06 |
Della-Cioppa Guy |
Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
|
US6080868A
(en)
|
1998-01-23 |
2000-06-27 |
The Perkin-Elmer Corporation |
Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
|
US6326479B1
(en)
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
US6020475A
(en)
*
|
1998-02-10 |
2000-02-01 |
Isis Pharmeuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
US7273933B1
(en)
*
|
1998-02-26 |
2007-09-25 |
Isis Pharmaceuticals, Inc. |
Methods for synthesis of oligonucleotides
|
US6111086A
(en)
|
1998-02-27 |
2000-08-29 |
Scaringe; Stephen A. |
Orthoester protecting groups
|
US6531590B1
(en)
|
1998-04-24 |
2003-03-11 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligonucleotide compounds
|
US6590092B1
(en)
*
|
1998-05-19 |
2003-07-08 |
Nam Q. Ngo |
Process for preparing a “universal support” and the reagents used for generating such support
|
US6274725B1
(en)
|
1998-06-02 |
2001-08-14 |
Isis Pharmaceuticals, Inc. |
Activators for oligonucleotide synthesis
|
US6919437B1
(en)
|
1998-06-11 |
2005-07-19 |
Isis Pharmaceuticals, Inc. |
Synthetic methods and intermediates for triester oligonucleotides
|
US6335439B1
(en)
|
1998-06-11 |
2002-01-01 |
Isis Pharmaceuticals, Inc. |
Method of preparing phosphoramidites
|
US6270730B1
(en)
|
1998-06-16 |
2001-08-07 |
Northwest Engineering Inc. |
Multi-well rotary synthesizer
|
US7087148B1
(en)
|
1998-06-23 |
2006-08-08 |
Clinical Micro Sensors, Inc. |
Binding acceleration techniques for the detection of analytes
|
US6326478B1
(en)
|
1998-07-08 |
2001-12-04 |
Isis Pharmaceuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
US6867294B1
(en)
|
1998-07-14 |
2005-03-15 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
US6242589B1
(en)
|
1998-07-14 |
2001-06-05 |
Isis Pharmaceuticals, Inc. |
Phosphorothioate oligonucleotides having modified internucleoside linkages
|
US6124484A
(en)
|
1998-07-17 |
2000-09-26 |
Isis Pharmaceuticals, Inc. |
Recovery of triarylmethyl halide protecting groups cleaved during oligonucleotide synthesis
|
US6271042B1
(en)
*
|
1998-08-26 |
2001-08-07 |
Alpha Innotech Corporation |
Biochip detection system
|
US6335437B1
(en)
|
1998-09-07 |
2002-01-01 |
Isis Pharmaceuticals, Inc. |
Methods for the preparation of conjugated oligomers
|
US6069243A
(en)
*
|
1998-10-06 |
2000-05-30 |
Isis Pharmaceuticals, Inc. |
Process for oligonucleotide synthesis
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
US6153411A
(en)
*
|
1998-10-30 |
2000-11-28 |
American Water Works Company, Inc. |
Methods and kits for detection of Cryptosporidium parvum using immunomagnetic separation and amplification
|
US6169177B1
(en)
|
1998-11-06 |
2001-01-02 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligomeric compounds
|
US6232075B1
(en)
|
1998-12-14 |
2001-05-15 |
Li-Cor, Inc. |
Heterogeneous assay for pyrophosphate detection
|
US6380378B1
(en)
|
1998-12-24 |
2002-04-30 |
Toagosei Company, Ltd. |
Nucleotide compound, nucleotide block oligonucleotide, and method for producing them
|
US6432642B1
(en)
*
|
1999-01-15 |
2002-08-13 |
Pe Corporation (Ny) |
Binary probe and clamp composition and methods for a target hybridization detection
|
US6465628B1
(en)
*
|
1999-02-04 |
2002-10-15 |
Isis Pharmaceuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
US6207819B1
(en)
|
1999-02-12 |
2001-03-27 |
Isis Pharmaceuticals, Inc. |
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
|
US6121437A
(en)
*
|
1999-03-16 |
2000-09-19 |
Isis Pharmaceuticals, Inc. |
Phosphate and thiophosphate protecting groups
|
US20040082774A1
(en)
*
|
1999-03-16 |
2004-04-29 |
Guzaev Andrei P. |
Novel phosphate and thiophosphate protecting groups
|
US6399765B1
(en)
|
1999-03-17 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Methods for removing dimethoxytrityl groups from oligonucleotides
|
CA2367912A1
(en)
|
1999-03-19 |
2000-09-28 |
Genencor International, Inc. |
Multi-through hole testing plate for high throughput screening
|
US6965041B1
(en)
|
1999-03-24 |
2005-11-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
N-acylphosphoramidites and their use in oligonucleotide synthesis
|
US20020177135A1
(en)
*
|
1999-07-27 |
2002-11-28 |
Doung Hau H. |
Devices and methods for biochip multiplexing
|
US6221635B1
(en)
|
1999-05-06 |
2001-04-24 |
The Wistar Institute |
Methods for solid-phase amplification of DNA template (SPADT) using multiarrays
|
US6610842B1
(en)
*
|
1999-05-06 |
2003-08-26 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligomers using phosphoramidite compositions
|
CA2375060A1
(en)
*
|
1999-05-24 |
2000-11-30 |
Invitrogen Corporation |
Method for deblocking of labeled oligonucleotides
|
US20070059752A1
(en)
*
|
1999-06-09 |
2007-03-15 |
Biosearch Technologies, Inc. |
Fluorescence energy transfer probes with stabilized conformations
|
US6750357B1
(en)
|
1999-06-25 |
2004-06-15 |
Syngen, Inc. |
Rhodamine-based fluorophores useful as labeling reagents
|
US7183405B2
(en)
|
1999-06-25 |
2007-02-27 |
Syn Gen, Inc. |
Compositions and methods for labeling oligonucleotides
|
US6593466B1
(en)
|
1999-07-07 |
2003-07-15 |
Isis Pharmaceuticals, Inc. |
Guanidinium functionalized nucleotides and precursors thereof
|
US6414135B1
(en)
|
1999-07-07 |
2002-07-02 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate monomers and related compounds
|
US6306599B1
(en)
|
1999-07-16 |
2001-10-23 |
Agilent Technologies Inc. |
Biopolymer arrays and their fabrication
|
US6346423B1
(en)
|
1999-07-16 |
2002-02-12 |
Agilent Technologies, Inc. |
Methods and compositions for producing biopolymeric arrays
|
US6147200A
(en)
*
|
1999-08-19 |
2000-11-14 |
Isis Pharmaceuticals, Inc. |
2'-O-acetamido modified monomers and oligomers
|
US6114518A
(en)
*
|
1999-09-30 |
2000-09-05 |
Becton, Dickinson And Company |
Synthesis and use of labelled phosphoramidite compositions
|
EP1218544B1
(en)
|
1999-10-04 |
2009-06-03 |
The University of Medicine and Dentistry of New Jersey |
TAR RNA binding peptides
|
US6451998B1
(en)
|
1999-10-18 |
2002-09-17 |
Agilent Technologies, Inc. |
Capping and de-capping during oligonucleotide synthesis
|
EP1230397A2
(en)
*
|
1999-11-02 |
2002-08-14 |
Celine Hu |
Molecular microarrays and methods for production and use thereof
|
US6361958B1
(en)
|
1999-11-12 |
2002-03-26 |
Motorola, Inc. |
Biochannel assay for hybridization with biomaterial
|
US6875619B2
(en)
|
1999-11-12 |
2005-04-05 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
AU1777401A
(en)
*
|
1999-11-17 |
2001-05-30 |
Xiuli Chen |
Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
|
US6716994B1
(en)
*
|
2000-01-04 |
2004-04-06 |
Applera Corporation |
Mobility-Modifying Cyanine Dyes
|
WO2001061054A2
(en)
|
2000-02-18 |
2001-08-23 |
Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and methods for parallel processing of micro-volume liquid reactions
|
US20020151040A1
(en)
|
2000-02-18 |
2002-10-17 |
Matthew O' Keefe |
Apparatus and methods for parallel processing of microvolume liquid reactions
|
US7019129B1
(en)
|
2000-05-09 |
2006-03-28 |
Biosearch Technologies, Inc. |
Dark quenchers for donor-acceptor energy transfer
|
EP1313880A2
(en)
*
|
2000-05-30 |
2003-05-28 |
PE Corporation (NY) |
Methods for detecting target nucleic acids using coupled ligation and amplification
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
JP2004516810A
(ja)
|
2000-06-07 |
2004-06-10 |
リ−コール インコーポレーティッド |
電荷スイッチヌクレオチド
|
US6936702B2
(en)
|
2000-06-07 |
2005-08-30 |
Li-Cor, Inc. |
Charge-switch nucleotides
|
US6869764B2
(en)
|
2000-06-07 |
2005-03-22 |
L--Cor, Inc. |
Nucleic acid sequencing using charge-switch nucleotides
|
EP1176151B1
(en)
|
2000-07-28 |
2014-08-20 |
Agilent Technologies, Inc. |
Synthesis of polynucleotides using combined oxidation/deprotection chemistry
|
ES2327316T3
(es)
|
2000-09-26 |
2009-10-28 |
Boston Probes, Inc. |
Sondas, conjuntos de sondas, metodos y kits que se refieren a la deteccion, identificacion y/o enumeracion de bacterias.
|
CA2425663C
(en)
*
|
2000-10-11 |
2009-12-29 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
US6693187B1
(en)
|
2000-10-17 |
2004-02-17 |
Lievre Cornu Llc |
Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
|
JP2004513629A
(ja)
*
|
2000-11-09 |
2004-05-13 |
インヴィトロジェン コーポレーション |
オリゴヌクレオチドからユニバーサルリンカーを除去する方法
|
EP1355672A2
(en)
|
2000-12-01 |
2003-10-29 |
Cell Works Inc. |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
|
US6794141B2
(en)
|
2000-12-22 |
2004-09-21 |
Arcturus Bioscience, Inc. |
Nucleic acid amplification
|
US6825338B2
(en)
|
2001-03-30 |
2004-11-30 |
Isis Pharmaceuticals, Inc. |
Labeled oligonucleotides, methods for making same, and compounds useful therefor
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
JP2004532213A
(ja)
*
|
2001-04-06 |
2004-10-21 |
ザ ユニヴァーシティ オヴ シカゴ |
Egr−1プロモーター活性の化学療法誘導
|
US20030170675A1
(en)
*
|
2001-04-11 |
2003-09-11 |
The Gov't Of The U.S Of America As Represented By The Secretary Of The Dept. Of Health & Human Serv. |
Methods of manipulating nucleic acids
|
EP1377683A4
(en)
*
|
2001-04-11 |
2004-09-08 |
Us Gov Health & Human Serv |
MODIFIED RANDOM SPRAYERS FOR PROBE MARKING
|
CA2381367A1
(en)
|
2001-04-12 |
2002-10-12 |
Hironori Komatsu |
Method for purifying 5'-protected 2'-deoxypurine nucleosides
|
US6867050B2
(en)
*
|
2001-05-16 |
2005-03-15 |
Academia Sinica |
Apparatus and methods for chemical synthesis
|
US20050009101A1
(en)
*
|
2001-05-17 |
2005-01-13 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
AU2002310012A1
(en)
|
2001-05-21 |
2002-12-03 |
Monogram Biosciences, Inc. |
Methods and compositions for analyzing proteins
|
US7300922B2
(en)
|
2001-05-25 |
2007-11-27 |
Duke University |
Modulators of pharmacological agents
|
EP1604688B1
(de)
|
2001-06-05 |
2010-02-03 |
CureVac GmbH |
Stabilisierte Tumorantigen-mRNA mit erhöhtem G/C-Gehalt
|
US7118907B2
(en)
*
|
2001-06-06 |
2006-10-10 |
Li-Cor, Inc. |
Single molecule detection systems and methods
|
WO2003003063A2
(en)
*
|
2001-06-28 |
2003-01-09 |
Ia, Inc. |
Fiber-optic sensor array
|
US7153954B2
(en)
|
2001-07-12 |
2006-12-26 |
Santaris Pharma A/S |
Method for preparation of LNA phosphoramidites
|
EP2053406A3
(en)
*
|
2001-07-16 |
2009-06-24 |
caprotec bioanalytics GmbH |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US6822088B2
(en)
|
2001-07-17 |
2004-11-23 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides on solid support
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
WO2003048308A2
(en)
|
2001-11-30 |
2003-06-12 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
WO2003048179A2
(en)
*
|
2001-12-03 |
2003-06-12 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
US7255874B1
(en)
|
2001-12-21 |
2007-08-14 |
Closure Medical Corporation |
Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto
|
GB0200526D0
(en)
*
|
2002-01-11 |
2002-02-27 |
Science And Technology The |
Methods
|
WO2003062452A2
(en)
*
|
2002-01-23 |
2003-07-31 |
Proligo, Llc |
Methods for the integrated synthesis and purification of oligonucleotides
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
WO2003064625A2
(en)
|
2002-02-01 |
2003-08-07 |
Sequitur, Inc. |
Oligonucleotide compositions with enhanced efficiency
|
DE60325847D1
(de)
*
|
2002-03-11 |
2009-03-05 |
Caprotec Bioanalytics Gmbh |
Verbindungen und verfahren für die analyse des proteoms
|
EP1485503A4
(en)
*
|
2002-03-15 |
2005-12-28 |
Arcturus Bioscience Inc |
IMPROVED NUCLEIC ACID AMPLIFICATION
|
US7169916B2
(en)
*
|
2002-04-01 |
2007-01-30 |
Isis Pharmaceuticals, Inc. |
Chloral-free DCA in oligonucleotide synthesis
|
KR100991052B1
(ko)
|
2002-05-08 |
2010-10-29 |
파나소닉 주식회사 |
생체분자 기판 및 그것을 이용한 검사 및 진단의 방법 및장치
|
WO2003102216A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Diversa Corporation |
Multiplexed systems for nucleic acid sequencing
|
CN100424091C
(zh)
|
2002-06-05 |
2008-10-08 |
三井化学株式会社 |
保护化2’-脱氧胞苷类的精制法
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
DE10229872A1
(de)
*
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
EP1386925A1
(en)
*
|
2002-07-31 |
2004-02-04 |
Girindus AG |
Method for preparing oligonucleotides
|
US8277753B2
(en)
|
2002-08-23 |
2012-10-02 |
Life Technologies Corporation |
Microfluidic transfer pin
|
ATE449103T1
(de)
*
|
2002-09-08 |
2009-12-15 |
Applera Corp |
Festphasengebundene pna-dimere und deren synthese
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
US7030230B2
(en)
|
2002-10-25 |
2006-04-18 |
Isis Pharmaceuticals, Inc. |
Process of purifying phosphoramidites
|
WO2004044136A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
|
US9150606B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
US9150605B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
KR20050083983A
(ko)
*
|
2002-12-09 |
2005-08-26 |
미쓰이 가가쿠 가부시키가이샤 |
포스포로아미다이트의 제조 방법
|
GB0229423D0
(en)
*
|
2002-12-18 |
2003-01-22 |
Avecia Ltd |
Process
|
CA2521999A1
(en)
|
2002-12-20 |
2004-09-02 |
Biotrove, Inc. |
Assay apparatus and method using microfluidic arrays
|
AU2002361255A1
(en)
*
|
2002-12-31 |
2004-07-22 |
Proligo Llc |
Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
|
CA2658334C
(en)
*
|
2003-01-16 |
2012-07-10 |
Caprotec Bioanalytics Gmbh |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7002006B2
(en)
*
|
2003-02-12 |
2006-02-21 |
Isis Pharmaceuticals, Inc. |
Protection of nucleosides
|
JP3936300B2
(ja)
*
|
2003-02-28 |
2007-06-27 |
独立行政法人科学技術振興機構 |
新規なグアノシン誘導体及びその用途
|
EP1613158A4
(en)
|
2003-03-27 |
2007-08-22 |
Ptc Therapeutics Inc |
METHOD FOR IDENTIFYING COMPOUNDS WITH A TRNA-SPLICEN ENDONUCLEASE AT THE PLACE OF ATTACK, AND USES THEREOF FOR PROVIDING THESE COMPOUNDS AS PROLIFERATION-INHIBITABLE AGENTS
|
JP2006521116A
(ja)
|
2003-03-27 |
2006-09-21 |
ピーティーシー セラピューティクス,インコーポレーテッド |
抗真菌性および/または抗増殖性分子を同定するためのtRNAスプライシング経路の酵素の標的化
|
US7745116B2
(en)
*
|
2003-04-08 |
2010-06-29 |
Pacific Biosciences Of California, Inc. |
Composition and method for nucleic acid sequencing
|
US20070179100A1
(en)
*
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
WO2004101582A2
(en)
*
|
2003-05-09 |
2004-11-25 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
CA2540692C
(en)
|
2003-06-02 |
2013-05-28 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide synthesis with alternative solvents
|
US20050239089A1
(en)
*
|
2003-06-06 |
2005-10-27 |
Johnson Martin D |
Mobility cassettes
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
EP1662863A4
(en)
*
|
2003-09-18 |
2009-01-28 |
Mayo Foundation |
TRANSGENIC NON-TIMES TIEG ANIMALS
|
JP5379347B2
(ja)
|
2003-09-18 |
2013-12-25 |
アイシス ファーマシューティカルズ, インコーポレーテッド |
4’−チオヌクレオシドおよびオリゴマー化合物
|
DK1692139T3
(da)
|
2003-11-13 |
2013-03-11 |
Isis Pharmaceuticals Inc |
5,6-dihydroxy-isoindol-derivater som linkere til fastfasesyntese af oligomerer
|
EP1704160B1
(en)
|
2003-12-22 |
2010-11-10 |
The Trustees of The University of Pennsylvania |
Methods and compositions for identifying rna-binding proteins
|
CA2553426A1
(en)
*
|
2004-01-15 |
2005-08-04 |
Alza Corporation |
Liposome composition for delivery of therapeutic agents
|
US7691316B2
(en)
*
|
2004-02-12 |
2010-04-06 |
Chemistry & Technology For Genes, Inc. |
Devices and methods for the synthesis of nucleic acids
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
EP1735097B1
(en)
|
2004-03-12 |
2016-11-30 |
Life Technologies Corporation |
Nanoliter array loading
|
KR101185050B1
(ko)
|
2004-04-22 |
2012-10-04 |
레가도 바이오사이언스, 인코포레이티드 |
응고 인자의 개선된 모듈레이터
|
JP4592060B2
(ja)
*
|
2004-04-26 |
2010-12-01 |
キヤノン株式会社 |
Pcr増幅反応装置、ならびに、該装置を利用するpcr増幅反応方法
|
IL162276A0
(en)
*
|
2004-06-01 |
2005-11-20 |
Hadasit Med Res Service |
Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof
|
US20090048192A1
(en)
*
|
2004-06-03 |
2009-02-19 |
Isis Pharmaceuticals, Inc. |
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
US20060105453A1
(en)
|
2004-09-09 |
2006-05-18 |
Brenan Colin J |
Coating process for microfluidic sample arrays
|
WO2006023880A2
(en)
|
2004-08-23 |
2006-03-02 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for the characterization of oligonucleotides
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
CA2581174A1
(en)
|
2004-09-16 |
2006-03-30 |
Applera Corporation |
Fluorescent dye compounds, conjugates and uses thereof
|
CA2580141C
(en)
|
2004-09-23 |
2013-12-10 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
US20070212695A1
(en)
*
|
2005-01-12 |
2007-09-13 |
Applera Corporation |
Compositions, methods, and kits for selective amplification of nucleic acids
|
US7608433B2
(en)
|
2005-02-09 |
2009-10-27 |
Idexx Laboratories |
Method of detection of classical swine fever
|
EP2505591A1
(en)
|
2005-02-11 |
2012-10-03 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for detecting a drug resistant EGFR mutant
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
US7741471B2
(en)
|
2005-05-26 |
2010-06-22 |
Eragen Biosciences, Inc. |
Reagents for the improved synthesis of isoguanosine containing oligonucleotides
|
US20090270479A1
(en)
*
|
2005-07-12 |
2009-10-29 |
Antonio Giordano |
Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer
|
US7892795B2
(en)
|
2005-08-02 |
2011-02-22 |
Focus Diagnostics, Inc. |
Methods and compositions for detecting BK virus
|
WO2007047408A2
(en)
*
|
2005-10-12 |
2007-04-26 |
Pathologica, Llc. |
Promac signature application
|
EP1949152A4
(en)
*
|
2005-11-14 |
2014-02-05 |
Bayer Ip Gmbh |
PLANAR WAVEGUIDE DETECTION CHIPS AND CHAMBERS FOR PERFORMING MULTIPLEX PCR ASSAYS
|
US7579459B2
(en)
*
|
2005-12-12 |
2009-08-25 |
Ngo Nam Q |
Activator bound solid supports for nucleic acid synthesis via the phosphoramidite approach
|
JP5342881B2
(ja)
|
2006-01-27 |
2013-11-13 |
アイシス ファーマシューティカルズ, インコーポレーテッド |
6−修飾された二環式核酸類似体
|
US7569686B1
(en)
|
2006-01-27 |
2009-08-04 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for synthesis of bicyclic nucleic acid analogs
|
WO2007095155A2
(en)
|
2006-02-13 |
2007-08-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Primers and probes for detection and discrimination of types and subtypes of influenza viruses
|
EP2012810A2
(en)
*
|
2006-03-24 |
2009-01-14 |
Archemix Corp. |
Solid support reagents for synthesis
|
CN103554205A
(zh)
|
2006-05-05 |
2014-02-05 |
Isis制药公司 |
调节gccr的表达的化合物和方法
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
AU2007249349B2
(en)
|
2006-05-11 |
2012-03-08 |
Isis Pharmaceuticals, Inc. |
5'-Modified bicyclic nucleic acid analogs
|
WO2007147110A2
(en)
*
|
2006-06-16 |
2007-12-21 |
Pacific Biosciences Of California, Inc. |
Controlled initiation of primer extension
|
JP2009543862A
(ja)
|
2006-07-14 |
2009-12-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ガンのバイオマーカーおよびその使用方法
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
WO2008014979A2
(en)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
US8138330B2
(en)
*
|
2006-09-11 |
2012-03-20 |
Sigma-Aldrich Co. Llc |
Process for the synthesis of oligonucleotides
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US8202983B2
(en)
|
2007-05-10 |
2012-06-19 |
Agilent Technologies, Inc. |
Thiocarbon-protecting groups for RNA synthesis
|
EP2152890A1
(en)
*
|
2007-05-23 |
2010-02-17 |
MannKind Corporation |
Multicistronic vectors and methods for their design
|
US8278425B2
(en)
|
2007-05-30 |
2012-10-02 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
EP2173760B2
(en)
|
2007-06-08 |
2015-11-04 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
CA2691364C
(en)
|
2007-06-19 |
2020-06-16 |
Stratos Genomics, Inc. |
High throughput nucleic acid sequencing by expansion
|
CN101796062B
(zh)
|
2007-07-05 |
2014-07-30 |
Isis制药公司 |
6-双取代双环核酸类似物
|
US8404830B2
(en)
*
|
2007-07-17 |
2013-03-26 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
WO2009023855A2
(en)
|
2007-08-15 |
2009-02-19 |
Isis Pharmaceuticals, Inc. |
Tetrahydropyran nucleic acid analogs
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
DK2548962T3
(en)
|
2007-09-19 |
2016-04-11 |
Applied Biosystems Llc |
Sirna sequence-independent modification formats to reduce off-target phenotype effects in RNAI and stabilized forms thereof
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
EP3222290A1
(en)
|
2007-10-09 |
2017-09-27 |
CureVac AG |
Composition for treating prostate cancer (pca)
|
US7829735B2
(en)
*
|
2007-10-26 |
2010-11-09 |
Northwestern University |
Universal phosphoramidite for preparation of modified biomolecules and surfaces
|
US8193339B2
(en)
*
|
2007-11-06 |
2012-06-05 |
Pharmaessentia Corp. |
Synthesis of β-nucleosides
|
SG188104A1
(en)
|
2008-01-31 |
2013-03-28 |
Curevac Gmbh |
Nucleic acids comprising formula (nuglxmgnnv)a and derivatives thereof as an immunostimulating agents /adjuvants
|
US8530640B2
(en)
|
2008-02-07 |
2013-09-10 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
CN104975020B
(zh)
|
2008-02-11 |
2020-01-17 |
菲奥医药公司 |
经修饰的RNAi多核苷酸及其用途
|
US8426378B2
(en)
|
2008-03-21 |
2013-04-23 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising tricyclic nucelosides and methods for their use
|
EP2285819B1
(en)
|
2008-04-04 |
2013-10-16 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising neutrally linked terminal bicyclic nucleosides
|
NZ589143A
(en)
|
2008-05-14 |
2012-02-24 |
Genomic Health Inc |
Colorectal cancer response prediction based on AREG EREG DUSP6 and SLC26A3 expression levels
|
US8636978B2
(en)
*
|
2008-06-23 |
2014-01-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclized NGR peptide compounds, compositions, and methods of their use
|
JP5438922B2
(ja)
*
|
2008-06-25 |
2014-03-12 |
日東電工株式会社 |
核酸の製造方法
|
WO2010008582A2
(en)
|
2008-07-18 |
2010-01-21 |
Rxi Pharmaceuticals Corporation |
Phagocytic cell drug delivery system
|
EP2949752B1
(en)
|
2008-09-22 |
2017-12-20 |
RXi Pharmaceuticals Corporation |
Reduced size self-delivering rnai compounds
|
EP3067359A1
(en)
|
2008-09-23 |
2016-09-14 |
Scott G. Petersen |
Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
|
DK2356129T3
(da)
|
2008-09-24 |
2013-05-13 |
Isis Pharmaceuticals Inc |
Substituerede alpha-L-bicykliske nukleosider
|
US8604192B2
(en)
|
2008-09-24 |
2013-12-10 |
Isis Pharmaceuticals, Inc. |
Cyclohexenyl nucleic acids analogs
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
SI2379084T1
(en)
|
2008-10-15 |
2018-04-30 |
Ionis Pharmaceuticals, Inc. |
Modulation of factor expression 11
|
WO2010048549A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
|
WO2010048585A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
US9074211B2
(en)
|
2008-11-19 |
2015-07-07 |
Rxi Pharmaceuticals Corporation |
Inhibition of MAP4K4 through RNAI
|
CA2744987C
(en)
|
2008-12-02 |
2018-01-16 |
Chiralgen, Ltd. |
Method for the synthesis of phosphorus atom modified nucleic acids
|
WO2010078536A1
(en)
|
2009-01-05 |
2010-07-08 |
Rxi Pharmaceuticals Corporation |
Inhibition of pcsk9 through rnai
|
RU2011134857A
(ru)
|
2009-01-21 |
2013-02-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы амплификации нуклеиновых кислот вируса гепатита с
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
WO2010090969A1
(en)
|
2009-02-06 |
2010-08-12 |
Isis Pharmaceuticals, Inc. |
Tetrahydropyran nucleic acid analogs
|
US8835117B2
(en)
|
2009-05-29 |
2014-09-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acids for detection and discrimination of genotypes of Chlamydophila psittaci
|
BR112012000828A8
(pt)
|
2009-07-06 |
2017-10-10 |
Ontorii Inc |
Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
|
EP2278334A1
(en)
|
2009-07-22 |
2011-01-26 |
Etablissement Francais du Sang |
A membrane based microarray device for high-throughput multianalyte detection
|
EP2462153B1
(en)
|
2009-08-06 |
2015-07-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
JP6184695B2
(ja)
|
2009-12-04 |
2017-08-23 |
ジェネンテック, インコーポレイテッド |
多重特異性抗体、抗体アナログ、組成物、及び方法
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
WO2011085102A1
(en)
|
2010-01-11 |
2011-07-14 |
Isis Pharmaceuticals, Inc. |
Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
|
WO2011094580A2
(en)
|
2010-01-28 |
2011-08-04 |
Alnylam Pharmaceuticals, Inc. |
Chelated copper for use in the preparation of conjugated oligonucleotides
|
US10113206B2
(en)
|
2010-02-24 |
2018-10-30 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
|
US9193752B2
(en)
|
2010-03-17 |
2015-11-24 |
Isis Pharmaceuticals, Inc. |
5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
|
WO2011119887A1
(en)
|
2010-03-24 |
2011-09-29 |
Rxi Pharmaceuticals Corporation |
Rna interference in dermal and fibrotic indications
|
EP3578183B1
(en)
|
2010-03-24 |
2021-09-08 |
Phio Pharmaceuticals Corp. |
Rna interference in ocular indications
|
RU2615143C2
(ru)
|
2010-03-24 |
2017-04-04 |
Адвирна |
Самодоставляющие PHKi соединения уменьшенного размера
|
EP3345915B1
(en)
|
2010-04-12 |
2021-11-24 |
Somalogic, Inc. |
5-position modified pyrimidines and their use
|
US20120003639A1
(en)
|
2010-04-27 |
2012-01-05 |
Prelude, Inc. |
Cancer biomarkers and methods of use thereof
|
WO2011139695A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom
|
EP2601204B1
(en)
|
2010-04-28 |
2016-09-07 |
Ionis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
WO2011139699A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
5' modified nucleosides and oligomeric compounds prepared therefrom
|
US8957200B2
(en)
|
2010-06-07 |
2015-02-17 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
CA2799540A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US8846637B2
(en)
|
2010-06-08 |
2014-09-30 |
Isis Pharmaceuticals, Inc. |
Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
ES2558106T3
(es)
|
2010-07-30 |
2016-02-02 |
Curevac Ag |
Formación de complejos de ácidos nucleicos con componentes catiónicos disulfuro-reticulados para la transfección e inmunoestimulación
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2012039448A1
(ja)
|
2010-09-24 |
2012-03-29 |
株式会社キラルジェン |
不斉補助基
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
JP6126009B2
(ja)
|
2010-11-17 |
2017-05-10 |
アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. |
α−シヌクレイン発現の調節
|
PT2658570T
(pt)
|
2010-12-27 |
2019-02-08 |
Elanco Us Inc |
Composições e métodos vacinais contra o vírus da diarreia viral bovina tipo 1b
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
EP3339440A1
(en)
|
2010-12-30 |
2018-06-27 |
Dow AgroSciences LLC |
Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
|
WO2012092580A2
(en)
|
2010-12-30 |
2012-07-05 |
Dow Agrosciences Llc |
Nucleic acid molecules that target the vacuolar atpase h subunit and confer resistance to coleopteran pests
|
CN103403162A
(zh)
|
2010-12-30 |
2013-11-20 |
陶氏益农公司 |
赋予对鞘翅目有害生物的抗性的核酸分子
|
JP2014503218A
(ja)
|
2010-12-30 |
2014-02-13 |
ダウ アグロサイエンシィズ エルエルシー |
Rho1低分子GTP結合タンパク質を標的とし、鞘翅目有害生物に対する抵抗性を付与する核酸分子
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
ES2537189T3
(es)
|
2011-05-24 |
2015-06-03 |
Elitech Holding B.V. |
Detección de estafilococos áureos resistentes a la meticilina
|
WO2012170347A1
(en)
|
2011-06-09 |
2012-12-13 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
EP2643460B1
(en)
|
2011-06-15 |
2017-07-26 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining human immunodeficiency virus (hiv)
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
EP2736916B1
(en)
|
2011-07-26 |
2019-05-22 |
ELITechGroup, Inc. |
Minor groove binder phosphoramidites and methods of use
|
BR112013031802A2
(pt)
|
2011-09-07 |
2016-12-20 |
Grifols Therapeutics Inc |
molécula de ácido nucleico isolada, composição, métodos para a amplificação de uma sequência alvo, e para a determinação de hav em uma amostra, e, kit
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
RU2707251C2
(ru)
|
2011-10-03 |
2019-11-25 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
US10557136B2
(en)
|
2011-12-12 |
2020-02-11 |
Oncolmmunin Inc. |
In vivo delivery of oligonucleotides
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
EP2833892A4
(en)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
|
EP2850092B1
(en)
|
2012-04-09 |
2017-03-01 |
Ionis Pharmaceuticals, Inc. |
Tricyclic nucleic acid analogs
|
WO2013154799A1
(en)
|
2012-04-09 |
2013-10-17 |
Isis Pharmaceuticals, Inc. |
Tricyclic nucleosides and oligomeric compounds prepared therefrom
|
ES2833524T3
(es)
|
2012-05-02 |
2021-06-15 |
Ibis Biosciences Inc |
Secuenciación de ADN
|
EP2844772B1
(en)
|
2012-05-02 |
2018-07-11 |
Ibis Biosciences, Inc. |
Dna sequencing
|
US10458915B2
(en)
|
2012-05-18 |
2019-10-29 |
Pacific Biosciences Of California, Inc. |
Heteroarylcyanine dyes
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
AU2013288048A1
(en)
|
2012-07-13 |
2015-01-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
KR101835401B1
(ko)
|
2012-07-13 |
2018-03-08 |
신 니뽄 바이오메디칼 라보라토리즈, 엘티디. |
키랄 핵산 어쥬번트
|
KR20220139425A
(ko)
|
2012-07-13 |
2022-10-14 |
웨이브 라이프 사이언시스 리미티드 |
키랄 제어
|
EP2885312A4
(en)
|
2012-08-15 |
2016-01-20 |
Isis Pharmaceuticals Inc |
PROCESS FOR THE PREPARATION OF OLIGOMERIC COMPOUNDS USING MODIFIED STREAMING PROTOCOLS
|
EP2885313A4
(en)
|
2012-08-20 |
2016-03-09 |
Univ California |
POLYNUCLEOTIDES WITH BIOREVERSIBLE GROUPS
|
WO2014030066A2
(en)
|
2012-08-22 |
2014-02-27 |
Bernitz Mats Nilsson |
Methods for identifying nucleic acid sequences
|
WO2014038561A1
(ja)
*
|
2012-09-04 |
2014-03-13 |
株式会社ダナフォーム |
化合物、核酸、標識物質および検出方法
|
IN2015DN02893A
(es)
|
2012-10-04 |
2015-09-11 |
Univ Leland Stanford Junior |
|
US9029335B2
(en)
|
2012-10-16 |
2015-05-12 |
Isis Pharmaceuticals, Inc. |
Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
EP2909341A2
(en)
|
2012-10-18 |
2015-08-26 |
Oslo Universitetssykehus HF |
Biomarkers for cervical cancer
|
EP3415638A1
(en)
|
2012-10-18 |
2018-12-19 |
IDEXX Laboratories, Inc. |
Nucleic acid amplification controls and kits and methods of use thereof
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
DK2951191T3
(en)
|
2013-01-31 |
2019-01-14 |
Ionis Pharmaceuticals Inc |
PROCEDURE FOR MANUFACTURING OLIGOMERIC COMPOUNDS USING MODIFIED CLUTCH PROTOCOLS
|
AU2014236396A1
(en)
|
2013-03-14 |
2015-08-13 |
Shire Human Genetic Therapies, Inc. |
Methods for purification of messenger RNA
|
AU2014239184B2
(en)
|
2013-03-14 |
2018-11-08 |
Translate Bio, Inc. |
Methods and compositions for delivering mRNA coded antibodies
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
EP2992009B1
(en)
|
2013-05-01 |
2020-06-24 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating apolipoprotein (a) expression
|
EP3004131B1
(en)
|
2013-06-05 |
2020-07-22 |
AM Chemicals Llc |
Phosphoramidite building blocks for sugar-conjugated oligonucleotides
|
US9069358B2
(en)
|
2013-06-24 |
2015-06-30 |
Biolytic Lab Performance, Inc. |
System for controlling and optimizing reactions in solid phase synthesis of small molecules
|
CN105637097A
(zh)
|
2013-08-05 |
2016-06-01 |
特韦斯特生物科学公司 |
从头合成的基因文库
|
EP3574916A1
(en)
|
2013-08-21 |
2019-12-04 |
CureVac AG |
Composition and vaccine for treating lung cancer
|
BR112016003361A2
(pt)
|
2013-08-21 |
2017-11-21 |
Curevac Ag |
vacina do vírus sincicial respiratório (rsv)
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
US9758546B2
(en)
|
2013-10-21 |
2017-09-12 |
Ionis Pharmaceuticals, Inc. |
Method for solution phase detritylation of oligomeric compounds
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
BR112016008832A2
(pt)
|
2013-10-22 |
2017-10-03 |
Shire Human Genetic Therapies |
Distribuição de mrna no snc e suas utilizações
|
WO2015061500A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for argininosuccinate synthetase deficiency
|
EA201690576A1
(ru)
|
2013-10-22 |
2016-10-31 |
Шир Хьюман Дженетик Терапис, Инк. |
Липидные композиции для доставки матричной рнк
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
US10172916B2
(en)
|
2013-11-15 |
2019-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating heart failure with agonists of hypocretin receptor 2
|
RU2732402C2
(ru)
|
2013-11-21 |
2020-09-16 |
Сомалоджик, Инк. |
Цитидин-5-карбоксамид модифицированные нуклеотидные композиции и способы, относящиеся к ним
|
EP3079707A4
(en)
|
2013-12-02 |
2017-10-18 |
RXi Pharmaceuticals Corporation |
Immunotherapy of cancer
|
BR102014031844A2
(pt)
|
2013-12-20 |
2015-10-06 |
Dow Agrosciences Llc |
ras oposto (rop) e moléculas de ácido nucleico relacionadas que conferem resistência a pragas de coleópteros e hemípteros
|
KR20160093728A
(ko)
|
2013-12-20 |
2016-08-08 |
다우 아그로사이언시즈 엘엘씨 |
딱정벌레류 해충에 대한 저항성을 부여하는 rnapii-140 핵산 분자
|
WO2015101415A1
(en)
|
2013-12-30 |
2015-07-09 |
Curevac Gmbh |
Artificial nucleic acid molecules
|
JP6704850B2
(ja)
|
2013-12-30 |
2020-06-03 |
キュアバック アーゲー |
人工核酸分子
|
EP3842537A1
(en)
|
2013-12-30 |
2021-06-30 |
CureVac AG |
Artificial nucleic acid molecules
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
EP3095461A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
PT3094728T
(pt)
|
2014-01-16 |
2022-05-19 |
Wave Life Sciences Ltd |
Desenho quiral
|
WO2015142910A1
(en)
|
2014-03-17 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
|
US10006027B2
(en)
|
2014-03-19 |
2018-06-26 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating Ataxin 2 expression
|
ES2890677T3
(es)
|
2014-03-19 |
2022-01-21 |
Ionis Pharmaceuticals Inc |
Composiciones para modular la expresión de ataxina 2
|
RS58337B1
(sr)
|
2014-03-24 |
2019-03-29 |
Translate Bio Inc |
Irnk terapija za lečenje očnih oboljenja
|
WO2015153800A2
(en)
|
2014-04-01 |
2015-10-08 |
Isis Pharmaceuticals, Inc. |
Compositions for modulating sod-1 expression
|
WO2015149944A2
(en)
|
2014-04-01 |
2015-10-08 |
Curevac Gmbh |
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
|
WO2015164693A1
(en)
|
2014-04-24 |
2015-10-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising alpha-beta-constrained nucleic acid
|
JP6571679B2
(ja)
|
2014-04-25 |
2019-09-04 |
トランスレイト バイオ, インコーポレイテッド |
メッセンジャーrnaの精製方法
|
WO2015168172A1
(en)
|
2014-04-28 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Linkage modified oligomeric compounds
|
CA2947270A1
(en)
|
2014-04-28 |
2015-11-05 |
Rxi Pharmaceuticals Corporation |
Methods for treating cancer using nucleic acids targeting mdm2 or mycn
|
WO2015168461A2
(en)
|
2014-04-30 |
2015-11-05 |
Agilent Technologies, Inc. |
Phosphorous protecting groups and methods of preparation and use thereof
|
ES2745825T3
(es)
|
2014-05-01 |
2020-03-03 |
Ionis Pharmaceuticals Inc |
Composiciones y métodos para modular la expresión del factor B del complemento
|
EP4223315A3
(en)
|
2014-05-01 |
2023-08-23 |
Ionis Pharmaceuticals, Inc. |
Method for synthesis of reactive conjugate clusters
|
AU2015255995B2
(en)
|
2014-05-07 |
2018-05-10 |
Dow Agrosciences Llc |
Dre4 nucleic acid molecules that confer resistance to coleopteran pests
|
US10018617B2
(en)
|
2014-05-16 |
2018-07-10 |
Life Technologies Corporation |
Carbopyronone compounds useful as diagnostic adjuvants
|
EP3587409B8
(en)
|
2014-05-30 |
2022-07-13 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US9802975B2
(en)
|
2014-06-10 |
2017-10-31 |
Agilent Technologies, Inc. |
Protecting groups for “Z nucleotide” and methods thereof
|
WO2015200465A1
(en)
|
2014-06-24 |
2015-12-30 |
Shire Human Genetic Therapies, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
JP6782171B2
(ja)
|
2014-07-02 |
2020-11-11 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
メッセンジャーrnaのカプセル化
|
US10093967B2
(en)
|
2014-08-12 |
2018-10-09 |
The Regents Of The University Of Michigan |
Detection of nucleic acids
|
US10900039B2
(en)
|
2014-09-05 |
2021-01-26 |
Phio Pharmaceuticals Corp. |
Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1
|
US10077318B2
(en)
|
2014-09-12 |
2018-09-18 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
WO2016040748A1
(en)
|
2014-09-12 |
2016-03-17 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for detection of smn protein in a subject and treatment of a subject
|
CN107027313B
(zh)
|
2014-10-17 |
2021-09-07 |
宾州研究基金会 |
用于多元rna引导的基因组编辑和其它rna技术的方法和组合物
|
EP3226912B1
(en)
|
2014-12-05 |
2021-01-20 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of articular disease
|
US11543411B2
(en)
|
2014-12-05 |
2023-01-03 |
Prelude Corporation |
DCIS recurrence and invasive breast cancer
|
WO2016094162A1
(en)
|
2014-12-12 |
2016-06-16 |
Elitechgroup B.V. |
Methods and compositions for detecting antibiotic resistant bacteria
|
JP2017538418A
(ja)
|
2014-12-12 |
2017-12-28 |
エリテックグループ・ベスローテン・フェンノートシャップElitechgroup B.V. |
抗生物質耐性細菌を検出する方法および組成物
|
PL3708668T3
(pl)
|
2014-12-12 |
2022-12-05 |
Curevac Ag |
Sztuczne cząsteczki kwasu nukleinowego dla poprawy ekspresji białka
|
US20160194658A1
(en)
|
2014-12-22 |
2016-07-07 |
Dow Agrosciences Llc |
Nucampholin nucleic acid molecules to control coleopteran insect pests
|
US9688707B2
(en)
|
2014-12-30 |
2017-06-27 |
Ionis Pharmaceuticals, Inc. |
Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
|
KR102580696B1
(ko)
|
2014-12-30 |
2023-09-19 |
큐어백 에스이 |
신규 인공 핵산 분자
|
US10793855B2
(en)
|
2015-01-06 |
2020-10-06 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
US10538763B2
(en)
|
2015-01-16 |
2020-01-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of DUX4
|
WO2016126882A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
CA2975855A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Compositions and methods for synthetic gene assembly
|
EP3262181B1
(en)
|
2015-02-23 |
2024-04-10 |
Ionis Pharmaceuticals, Inc. |
Method for solution phase detritylation of oligomeric compounds
|
US11129844B2
(en)
|
2015-03-03 |
2021-09-28 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating MECP2 expression
|
EP3067424A1
(en)
|
2015-03-13 |
2016-09-14 |
Dow AgroSciences LLC |
Rna polymerase i1 nucleic acid molecules to control insect pests
|
CA2979695A1
(en)
|
2015-03-19 |
2016-09-22 |
Translate Bio, Inc. |
Mrna therapy for pompe disease
|
US10407678B2
(en)
|
2015-04-16 |
2019-09-10 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
BR102016012010A2
(pt)
|
2015-05-29 |
2020-03-24 |
Dow Agrosciences Llc |
Molécula de ácido nucleico, de ácido ribonucleico (rna) e de ácido ribonucleico de filamento duplo (dsrna), usos de célula, planta e semente, produto primário, bem como métodos para controlar uma população de pragas coleópteras e/ou hemípteras, para melhorar o rendimento de uma cultura, e para produzir uma célula vegetal transgênica e uma planta transgênica
|
GB201511470D0
(en)
|
2015-06-30 |
2015-08-12 |
Cellcall Kft |
HPV detection method
|
JP6983752B2
(ja)
|
2015-07-06 |
2021-12-17 |
フィオ ファーマシューティカルズ コーポレーションPhio Pharmaceuticals Corp. |
スーパーオキシドディスムターゼ1(sod1)を標的とする核酸分子
|
US10808247B2
(en)
|
2015-07-06 |
2020-10-20 |
Phio Pharmaceuticals Corp. |
Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
|
MA43072A
(fr)
|
2015-07-22 |
2018-05-30 |
Wave Life Sciences Ltd |
Compositions d'oligonucléotides et procédés associés
|
JP6882782B2
(ja)
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
|
WO2017036580A1
(en)
|
2015-08-28 |
2017-03-09 |
Curevac Ag |
Artificial nucleic acid molecules
|
US10844373B2
(en)
|
2015-09-18 |
2020-11-24 |
Twist Bioscience Corporation |
Oligonucleic acid variant libraries and synthesis thereof
|
CN108698012A
(zh)
|
2015-09-22 |
2018-10-23 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
EP3353303B1
(en)
|
2015-09-25 |
2023-08-02 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating ataxin 3 expression
|
WO2017070151A1
(en)
|
2015-10-19 |
2017-04-27 |
Rxi Pharmaceuticals Corporation |
Reduced size self-delivering nucleic acid compounds targeting long non-coding rna
|
CN115920796A
(zh)
|
2015-12-01 |
2023-04-07 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
WO2017096395A1
(en)
|
2015-12-04 |
2017-06-08 |
Ionis Pharmaceuticals, Inc. |
Methods of treating breast cancer
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
WO2017120365A1
(en)
|
2016-01-05 |
2017-07-13 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing lrrk2 expression
|
AU2017234678A1
(en)
|
2016-03-16 |
2018-08-16 |
Ionis Pharmaceuticals, Inc. |
Methods of modulating KEAP1
|
US10577607B2
(en)
|
2016-03-16 |
2020-03-03 |
Ionis Pharmaceuticals, Inc. |
Modulation of DYRK1B expression
|
KR102475301B1
(ko)
|
2016-04-08 |
2022-12-09 |
트랜슬레이트 바이오 인코포레이티드 |
다량체 코딩 핵산 및 그 용도
|
EP3443123B1
(en)
|
2016-04-11 |
2021-08-11 |
Board of Regents, The University of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
US11467156B2
(en)
|
2016-06-01 |
2022-10-11 |
Duke University |
Nonfouling biosensors
|
JP2019522047A
(ja)
|
2016-06-13 |
2019-08-08 |
トランスレイト バイオ, インコーポレイテッド |
オルニチントランスカルバミラーゼ欠損症治療のためのメッセンジャーrna療法
|
AU2017286811A1
(en)
|
2016-06-17 |
2018-11-22 |
Ionis Pharmaceuticals, Inc. |
Modulation of gys1 expression
|
WO2018013999A1
(en)
|
2016-07-15 |
2018-01-18 |
Am Chemicals Llc |
Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis
|
CN109963871A
(zh)
|
2016-08-05 |
2019-07-02 |
豪夫迈·罗氏有限公司 |
具有激动活性的多价及多表位抗体以及使用方法
|
EP3500581A4
(en)
|
2016-08-17 |
2021-10-06 |
Solstice Biologics, Ltd. |
POLYNUCLEOTIDE CONSTRUCTS
|
EP3500270A1
(en)
|
2016-08-19 |
2019-06-26 |
Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal |
Mir-127 agents for use in the treatment of renal fibrosis
|
EP3500672A4
(en)
|
2016-08-22 |
2020-05-20 |
Twist Bioscience Corporation |
NOVO SYNTHESIZED NUCLEIC ACID BANKS
|
KR102217487B1
(ko)
|
2016-09-21 |
2021-02-23 |
트위스트 바이오사이언스 코포레이션 |
핵산 기반 데이터 저장
|
US11400161B2
(en)
|
2016-10-06 |
2022-08-02 |
Ionis Pharmaceuticals, Inc. |
Method of conjugating oligomeric compounds
|
EP3538073A1
(en)
|
2016-11-10 |
2019-09-18 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
IL266501B2
(en)
|
2016-11-10 |
2024-06-01 |
Translate Bio Inc |
An improved ICE-based lipid nanoparticle formulation for delivery of mRNA
|
WO2018089237A1
(en)
|
2016-11-10 |
2018-05-17 |
Dow Agrosciences Llc |
Cytochrome b (cytb) nucleic acid molecules that control pathogens
|
EP3538136A1
(en)
|
2016-11-10 |
2019-09-18 |
Translate Bio, Inc. |
Subcutaneous delivery of messenger rna
|
JOP20190104A1
(ar)
|
2016-11-10 |
2019-05-07 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن atxn3
|
US11033570B2
(en)
|
2016-12-02 |
2021-06-15 |
Cold Spring Harbor Laboratory |
Modulation of Lnc05 expression
|
KR102514213B1
(ko)
|
2016-12-16 |
2023-03-27 |
트위스트 바이오사이언스 코포레이션 |
면역 시냅스의 변이체 라이브러리 및 그의 합성
|
EP3342780A1
(en)
|
2016-12-30 |
2018-07-04 |
Dow AgroSciences LLC |
Pre-mrna processing factor 8 (prp8) nucleic acid molecules to control insect pests
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
SG11201907713WA
(en)
|
2017-02-22 |
2019-09-27 |
Twist Bioscience Corp |
Nucleic acid based data storage
|
US10808241B2
(en)
|
2017-02-27 |
2020-10-20 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
AU2018224318B2
(en)
|
2017-02-27 |
2024-06-20 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
WO2018165257A1
(en)
|
2017-03-07 |
2018-09-13 |
Translate Bio, Inc. |
Polyanionic delivery of nucleic acids
|
US11180756B2
(en)
|
2017-03-09 |
2021-11-23 |
Ionis Pharmaceuticals |
Morpholino modified oligomeric compounds
|
WO2018170169A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
MA49138A
(fr)
|
2017-05-16 |
2020-03-25 |
Translate Bio Inc |
Traitement de la fibrose kystique par administration d'arnm à codons optimisés codant pour la cftr
|
SG11201912057RA
(en)
|
2017-06-12 |
2020-01-30 |
Twist Bioscience Corp |
Methods for seamless nucleic acid assembly
|
WO2018231709A1
(en)
|
2017-06-12 |
2018-12-20 |
Translate Bio, Inc. |
Poly(phosphoesters) for delivery of nucleic acids
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
US10780183B2
(en)
|
2017-06-19 |
2020-09-22 |
Translate Bio, Inc. |
Messenger RNA therapy for the treatment of Friedreich's ataxia
|
US11597744B2
(en)
|
2017-06-30 |
2023-03-07 |
Sirius Therapeutics, Inc. |
Chiral phosphoramidite auxiliaries and methods of their use
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
EP3668984A4
(en)
|
2017-08-18 |
2021-09-08 |
Ionis Pharmaceuticals, Inc. |
MODULATION OF THE NOTCH SIGNALING PATH FOR THE TREATMENT OF RESPIRATORY DISORDERS
|
WO2019051173A1
(en)
|
2017-09-08 |
2019-03-14 |
Ionis Pharmaceuticals, Inc. |
MODULATORS OF SMAD7 EXPRESSION
|
WO2019051501A1
(en)
|
2017-09-11 |
2019-03-14 |
Twist Bioscience Corporation |
PROTEINS BINDING TO GPCR AND METHODS OF SYNTHESIS
|
JP7066840B2
(ja)
|
2017-10-20 |
2022-05-13 |
ツイスト バイオサイエンス コーポレーション |
ポリヌクレオチド合成のための加熱されたナノウェル
|
TWI809004B
(zh)
|
2017-11-09 |
2023-07-21 |
美商Ionis製藥公司 |
用於降低snca表現之化合物及方法
|
EP3727428A1
(en)
|
2017-12-20 |
2020-10-28 |
Translate Bio, Inc. |
Improved composition and methods for treatment of ornithine transcarbamylase deficiency
|
WO2019126641A2
(en)
|
2017-12-21 |
2019-06-27 |
Ionis Pharmaceuticals, Inc. |
Modulation of frataxin expression
|
EP3735459A4
(en)
|
2018-01-04 |
2021-10-06 |
Twist Bioscience Corporation |
DNA-BASED DIGITAL INFORMATION STORAGE
|
EP3740575A1
(en)
|
2018-01-15 |
2020-11-25 |
Ionis Pharmaceuticals, Inc. |
Modulators of dnm2 expression
|
EP3746496A1
(en)
|
2018-02-02 |
2020-12-09 |
Translate Bio, Inc. |
Cationic polymers
|
EP3759127A4
(en)
|
2018-03-02 |
2022-03-30 |
Ionis Pharmaceuticals, Inc. |
COMPOUNDS AND METHODS FOR MODULATING AMYLOID BETA PRECURSOR PROTEIN
|
MX2020009147A
(es)
|
2018-03-02 |
2020-09-28 |
Ionis Pharmaceuticals Inc |
Moduladores de la expresion de irf4.
|
EP3768694A4
(en)
|
2018-03-22 |
2021-12-29 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating fmr1 expression
|
WO2019200172A1
(en)
|
2018-04-11 |
2019-10-17 |
Ionis Pharmaceuticals, Inc. |
Modulators of ezh2 expression
|
AU2019252812A1
(en)
|
2018-04-13 |
2020-10-01 |
Bristol-Myers Squibb Company |
Novel phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds
|
WO2019217572A1
(en)
|
2018-05-08 |
2019-11-14 |
Sanford Burnham Prebys Medical Discovery Institute |
Role of pvt1 in the diagnosis and treatment of myc-driven cancer
|
JP2021522800A
(ja)
|
2018-05-09 |
2021-09-02 |
アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. |
Atxn3発現を低減するための化合物及び方法
|
EP3799604A4
(en)
|
2018-05-09 |
2022-09-07 |
Ionis Pharmaceuticals, Inc. |
COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION
|
JP7448488B2
(ja)
|
2018-05-15 |
2024-03-12 |
トランスレイト バイオ, インコーポレイテッド |
メッセンジャーrnaの皮下送達
|
CA3100218A1
(en)
|
2018-05-16 |
2019-11-21 |
Translate Bio, Inc. |
Ribose cationic lipids
|
KR20210013128A
(ko)
|
2018-05-18 |
2021-02-03 |
트위스트 바이오사이언스 코포레이션 |
핵산 하이브리드화를 위한 폴리뉴클레오타이드, 시약 및 방법
|
CN112437767B
(zh)
|
2018-05-24 |
2023-10-27 |
川斯勒佰尔公司 |
硫酯阳离子脂质
|
US20210206739A1
(en)
|
2018-05-30 |
2021-07-08 |
Translate Bio, Inc. |
Vitamin Cationic Lipids
|
EP3801627A1
(en)
|
2018-05-30 |
2021-04-14 |
Translate Bio, Inc. |
Phosphoester cationic lipids
|
KR20210056953A
(ko)
|
2018-05-30 |
2021-05-20 |
트랜슬레이트 바이오 인코포레이티드 |
전령 rna 백신 및 이의 용도
|
CN112424214A
(zh)
|
2018-05-30 |
2021-02-26 |
川斯勒佰尔公司 |
包含甾族部分的阳离子脂质
|
US11384376B2
(en)
|
2018-05-31 |
2022-07-12 |
Roche Molecular Systems, Inc. |
Reagents and methods for post-synthetic modification of nucleic acids
|
WO2019241648A1
(en)
|
2018-06-14 |
2019-12-19 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for increasing stmn2 expression
|
TWI833770B
(zh)
|
2018-06-27 |
2024-03-01 |
美商Ionis製藥公司 |
用於減少 lrrk2 表現之化合物及方法
|
EP3814498A1
(en)
|
2018-06-29 |
2021-05-05 |
Eberhard-Karls-Universität Tübingen |
Artificial nucleic acids for rna editing
|
EP3826608A1
(en)
|
2018-07-23 |
2021-06-02 |
Translate Bio, Inc. |
Dry power formulations for messenger rna
|
AU2019310097A1
(en)
|
2018-07-25 |
2021-02-04 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing ATXN2 expression
|
EP3829622A4
(en)
|
2018-08-02 |
2022-05-11 |
Duke University |
DUAL AGONIST FUSION PROTEINS
|
AU2019325702A1
(en)
|
2018-08-24 |
2021-02-25 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
WO2020047061A1
(en)
|
2018-08-29 |
2020-03-05 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
WO2020056338A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
WO2020056294A1
(en)
|
2018-09-14 |
2020-03-19 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
CA3112837A1
(en)
|
2018-10-19 |
2020-04-23 |
Translate Bio, Inc. |
Pumpless encapsulation of messenger rna
|
EP3877538A1
(en)
|
2018-11-08 |
2021-09-15 |
Translate Bio, Inc. |
Methods and compositions for messenger rna purification
|
EP3877444A1
(en)
|
2018-11-09 |
2021-09-15 |
Translate Bio, Inc. |
Multi-peg lipid compounds
|
CN113272282A
(zh)
|
2018-11-09 |
2021-08-17 |
川斯勒佰尔公司 |
具有插入的酯、硫酯、二硫化物和酸酐部分的2,5-二氧代哌嗪脂质
|
WO2020097379A2
(en)
|
2018-11-09 |
2020-05-14 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
US20220016265A1
(en)
|
2018-11-09 |
2022-01-20 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
AU2019378763A1
(en)
|
2018-11-12 |
2021-06-03 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
TW202028222A
(zh)
|
2018-11-14 |
2020-08-01 |
美商Ionis製藥公司 |
Foxp3表現之調節劑
|
EP3880821A4
(en)
|
2018-11-15 |
2023-01-25 |
Ionis Pharmaceuticals, Inc. |
IRF5 EXPRESSION MODULATORS
|
EP3883592A1
(en)
|
2018-11-21 |
2021-09-29 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr
|
EP3883917B1
(en)
|
2018-11-21 |
2024-01-24 |
Translate Bio, Inc. |
Cationic lipid compounds and compositions thereof for use in the delivery of messenger rna
|
US20220087935A1
(en)
|
2019-01-07 |
2022-03-24 |
Translate Bio, Inc. |
Composition and Methods for Treatment of Primary Ciliary Dyskinesia
|
CA3128093A1
(en)
|
2019-01-31 |
2020-08-06 |
Ionis Pharmaceuticals, Inc. |
Modulators of yap1 expression
|
CN113766930A
(zh)
|
2019-02-26 |
2021-12-07 |
特韦斯特生物科学公司 |
Glp1受体的变异核酸文库
|
CA3131691A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
MX2021010152A
(es)
|
2019-02-27 |
2021-09-14 |
Ionis Pharmaceuticals Inc |
Moduladores de la expresion de malat1.
|
MX2021011916A
(es)
|
2019-03-29 |
2021-10-26 |
Ionis Pharmaceuticals Inc |
Compuestos y metodos para modular ube3a-ats.
|
EP3956303A1
(en)
|
2019-04-18 |
2022-02-23 |
Translate Bio, Inc. |
Cystine cationic lipids
|
ES2972014T3
(es)
|
2019-04-22 |
2024-06-10 |
Translate Bio Inc |
Lípidos catiónicos de tioéster
|
US20220257724A1
(en)
|
2019-05-03 |
2022-08-18 |
Translate Bio, Inc. |
Di-thioester cationic lipids
|
SG11202112574RA
(en)
|
2019-05-14 |
2021-12-30 |
Translate Bio Inc |
Improved process of preparing mrna-loaded lipid nanoparticles
|
US11453877B2
(en)
|
2019-05-15 |
2022-09-27 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
EP3976593A1
(en)
|
2019-05-31 |
2022-04-06 |
Translate Bio, Inc. |
Macrocyclic lipids
|
CA3144457A1
(en)
|
2019-06-21 |
2020-12-24 |
Translate Bio, Inc. |
Tricine and citric acid lipids
|
WO2020257611A1
(en)
|
2019-06-21 |
2020-12-24 |
Translate Bio, Inc. |
Cationic lipids comprising an hydroxy moiety
|
US11332738B2
(en)
|
2019-06-21 |
2022-05-17 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
JP2022541740A
(ja)
|
2019-07-08 |
2022-09-27 |
トランスレイト バイオ, インコーポレイテッド |
改善されたmRNA装填脂質ナノ粒子、およびそれを作製するプロセス
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
JP2022542562A
(ja)
|
2019-07-23 |
2022-10-05 |
トランスレイト バイオ, インコーポレイテッド |
mRNA担持脂質ナノ粒子の安定性組成物および作製のプロセス
|
EP3956450A4
(en)
|
2019-07-26 |
2022-11-16 |
Ionis Pharmaceuticals, Inc. |
COMPOUNDS AND METHODS FOR MODULATION OF GFAP
|
WO2021021988A1
(en)
|
2019-07-30 |
2021-02-04 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr
|
WO2021030778A1
(en)
|
2019-08-15 |
2021-02-18 |
Ionis Pharmaceuticals, Inc. |
Linkage modified oligomeric compounds and uses thereof
|
CN115461042A
(zh)
|
2019-12-20 |
2022-12-09 |
翻译生物公司 |
制备负载mrna的脂质纳米颗粒的改进方法
|
IL294073A
(en)
|
2019-12-20 |
2022-08-01 |
Translate Bio Inc |
Rectal administration of messenger rna
|
WO2021142245A1
(en)
|
2020-01-10 |
2021-07-15 |
Translate Bio, Inc. |
Compounds, pharmaceutical compositions and methods for modulating expression of muc5b in lung cells and tissues
|
CN115443338A
(zh)
|
2020-02-10 |
2022-12-06 |
翻译生物公司 |
用于信使rna纯化的方法和组合物
|
AU2021226578A1
(en)
|
2020-02-25 |
2022-10-20 |
Translate Bio, Inc. |
Improved processes of preparing mRNA-loaded lipid nanoparticles
|
CA3173034A1
(en)
|
2020-02-28 |
2021-09-02 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating smn2
|
JP2023520047A
(ja)
|
2020-04-01 |
2023-05-15 |
トランスレイト バイオ, インコーポレイテッド |
フェノール酸脂質系カチオン性脂質
|
EP4127175A2
(en)
|
2020-04-02 |
2023-02-08 |
Mirecule, Inc. |
Targeted inhibition using engineered oligonucleotides
|
CN116096380A
(zh)
|
2020-05-01 |
2023-05-09 |
Ionis制药公司 |
调节atxn1的化合物和方法
|
EP4146680A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
WO2021231697A1
(en)
|
2020-05-14 |
2021-11-18 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
WO2021231901A1
(en)
|
2020-05-15 |
2021-11-18 |
Translate Bio, Inc. |
Lipid nanoparticle formulations for mrna delivery
|
WO2022006134A2
(en)
|
2020-06-29 |
2022-01-06 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating plp1
|
WO2022006527A1
(en)
|
2020-07-02 |
2022-01-06 |
Maritime Therapeutics, Inc. |
Compositions and methods for reverse gene therapy
|
EP4216933A1
(en)
|
2020-09-23 |
2023-08-02 |
Translate Bio, Inc. |
Piperazine-based cationic lipids
|
WO2022066678A1
(en)
|
2020-09-23 |
2022-03-31 |
Translate Bio, Inc. |
Tes-based cationic lipids
|
WO2022072836A2
(en)
|
2020-10-01 |
2022-04-07 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
AU2021358777A1
(en)
|
2020-10-06 |
2023-06-15 |
Translate Bio, Inc. |
Improved process and formulation of lipid nanoparticles
|
WO2022081544A1
(en)
|
2020-10-12 |
2022-04-21 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
US20220133631A1
(en)
|
2020-10-12 |
2022-05-05 |
Translate Bio, Inc. |
Process of preparing ice-based lipid nanoparticles
|
WO2022078569A1
(en)
|
2020-10-12 |
2022-04-21 |
Eberhard Karls Universität Tübingen |
Artificial nucleic acids for rna editing
|
US11771652B2
(en)
|
2020-11-06 |
2023-10-03 |
Sanofi |
Lipid nanoparticles for delivering mRNA vaccines
|
CA3201661A1
(en)
|
2020-11-18 |
2022-05-27 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating angiotensinogen expression
|
MX2023007257A
(es)
|
2020-12-18 |
2023-07-03 |
Ionis Pharmaceuticals Inc |
Compuestos y metodos para modular el factor xii.
|
WO2022178438A1
(en)
|
2021-02-22 |
2022-08-25 |
Duke University |
Non-immunogenic poegma-aptamer conjugates
|
TW202309002A
(zh)
|
2021-04-15 |
2023-03-01 |
美商轉譯生技公司 |
基於「古德」緩衝液的陽離子脂質
|
WO2022240960A1
(en)
|
2021-05-14 |
2022-11-17 |
Crispr Therapeutics Ag |
Mrna large scale synthesis and purification
|
WO2022261075A1
(en)
|
2021-06-07 |
2022-12-15 |
The Board Of Trustees Of The University Of Illinois |
Photoactivatable gasdermin proteins
|
CN117500815A
(zh)
|
2021-06-18 |
2024-02-02 |
Ionis制药公司 |
用于降低ifnar1表达的化合物和方法
|
CA3224175A1
(en)
|
2021-06-18 |
2022-12-22 |
Sanofi |
Multivalent influenza vaccines
|
CA3223876A1
(en)
|
2021-07-14 |
2023-01-19 |
Anthony SALEH |
Oligonucleotides and compositions thereof for neuromuscular disorders
|
WO2023031856A1
(en)
|
2021-09-02 |
2023-03-09 |
Sanofi |
Compositions and methods for rna affinity purification
|
WO2023035003A1
(en)
|
2021-09-03 |
2023-03-09 |
Elegen Corp. |
Multi-way bead-sorting devices, systems, and methods of use thereof using pressure sources
|
KR20240065326A
(ko)
|
2021-10-05 |
2024-05-14 |
사노피 |
지질 나노입자(lnp)를 냉동 및 냉동-건조하는 방법 및 이를 사용하여 수득된 lnp
|
WO2023059412A1
(en)
|
2021-10-05 |
2023-04-13 |
Microsoft Technology Licensing, Llc |
Regulation of dna synthesis by nucleotides linked to protecting groups
|
WO2023077107A1
(en)
|
2021-10-29 |
2023-05-04 |
Sana Biotechnology, Inc. |
Methods and reagents for amplifying viral vector nucleic acid products
|
US20230302112A1
(en)
|
2021-11-05 |
2023-09-28 |
Sanofi |
Respiratory synctial virus rna vaccine
|
AU2022388747A1
(en)
|
2021-11-10 |
2024-06-20 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
WO2023102373A1
(en)
|
2021-11-30 |
2023-06-08 |
Sanofi Pasteur Inc. |
Human metapneumovirus vaccines
|
WO2023111262A1
(en)
|
2021-12-17 |
2023-06-22 |
Sanofi |
Lyme disease rna vaccine
|
WO2023135305A1
(en)
|
2022-01-17 |
2023-07-20 |
Sanofi |
Lipidic compounds, and uses thereof
|
WO2023178167A1
(en)
|
2022-03-16 |
2023-09-21 |
Translate Bio, Inc. |
Asymmetric piperazine-based cationic lipids
|
WO2023186842A1
(en)
|
2022-03-28 |
2023-10-05 |
F. Hoffmann-La Roche Ag |
Synthesis of isomerically pure polyol-based phosphoramidites
|
WO2023198857A1
(en)
|
2022-04-13 |
2023-10-19 |
Sanofi |
"good" buffer-based cationic lipids
|
TW202408567A
(zh)
|
2022-05-06 |
2024-03-01 |
法商賽諾菲公司 |
用於核酸疫苗之訊息序列
|
WO2023242425A1
(en)
|
2022-06-17 |
2023-12-21 |
Sanofi |
Compositions and methods for circular rna affinity purification
|
WO2024002924A2
(en)
|
2022-06-28 |
2024-01-04 |
F. Hoffmann-La Roche Ag |
Fluorescent dyes with large stokes shift
|
US20240043826A1
(en)
|
2022-07-29 |
2024-02-08 |
Sanofi |
Methods for ethanol-free mrna purification
|
WO2024044108A1
(en)
|
2022-08-22 |
2024-02-29 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Vaccines against coronaviruses
|
EP4360657A1
(en)
|
2022-10-28 |
2024-05-01 |
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal |
Mir-326 for the treatment of cancer
|
WO2024094881A1
(en)
|
2022-11-04 |
2024-05-10 |
Sanofi |
Respiratory syncytial virus rna vaccination
|
WO2024094876A1
(en)
|
2022-11-04 |
2024-05-10 |
Sanofi |
Methods for messenger rna tailing
|
WO2024099575A1
(en)
|
2022-11-11 |
2024-05-16 |
Eberhard Karls Universität Tübingen |
Artificial nucleic acids for site-directed editing of a target rna
|
WO2024112652A1
(en)
|
2022-11-21 |
2024-05-30 |
Translate Bio, Inc. |
Compositions of dry powder formulations of messenger rna and methods of use thereof
|
WO2024126847A1
(en)
|
2022-12-15 |
2024-06-20 |
Sanofi |
Mrna recombinant capping enzymes
|